David

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA 10 PHARMACEUTICAL RESEARCH AND No. 2:17-cv-02573-MCE-KJN

MANUFACTURERS OF AMERICA,

12 Plaintiff, ORDER v. 14 ROBERT P. DAVID, in his official capacity as Director of the California Office of Statewide Health Planning and Development, Defendant. 18 Through the present action, Plaintiff Pharmaceutical Research and Manufacturers of America (“PhRMA” or “Plaintiff”) seeks a declaration that Section 4 of a California law, Senate Bill 17 (“SB 17”), which imposes various notice, reporting, and justification obligations on the manufacturer of a prescription drug sold to certain purchasers, is unconstitutional. PhRMA seeks injunctive relief preventing implementation of SB 17 by Defendant Robert P. David, Director of the Office of Statewide Health Planning and Development (“OSHPD” or “Defendant”). This Court recently denied PhRMA’s motion for summary judgment. PhRMA now seeks leave to pursue an interlocutory appeal of ///

1 Elizabeth Landsberg has…